Skip to main content

Abrysvo Side Effects

Generic name: rsv vaccine, pref a-pref b, recombinant

Medically reviewed by Drugs.com. Last updated on May 31, 2023.

Note: This document contains side effect information about rsv vaccine, pref a-pref b, recombinant. Some dosage forms listed on this page may not apply to the brand name Abrysvo.

Applies to rsv vaccine, pref a-pref b, recombinant: intramuscular powder for solution, intramuscular powder for suspension.

Serious side effects of Abrysvo

Along with its needed effects, rsv vaccine, pref a-pref b, recombinant (the active ingredient contained in Abrysvo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking rsv vaccine, pref a-pref b, recombinant:

Less common

Incidence not known

Other side effects of Abrysvo

Some side effects of rsv vaccine, pref a-pref b, recombinant may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Rare

For Healthcare Professionals

Applies to rsv vaccine, pref a-pref b, recombinant: intramuscular injection.

General

The most reported adverse reactions were injection site pain (10.5%), fatigue (15.5%), headache (12.8%), and muscle pain (10.1%)[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, diarrhea

Uncommon (0.1% to 1%): Vomiting[Ref]

Local

Very common (10% or more): Pain (10.5%)

Common (1% to 10%): Redness, swelling[Ref]

Musculoskeletal

Very common (10% or more): Muscle pain (10.1%)

Common (1% to 10%): Joint pain[Ref]

Nervous system

Very common (10% or more): Headache (12.8%)

Common (1% to 10%): Grade 3 headache (prevents normal daily activities)[Ref]

Other

Very common (10% or more): Fatigue (15.5%)

Common (1% to 10%): Fever of 38C or greater[Ref]

Frequently asked questions

References

1. Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant). Pfizer U.S. Pharmaceuticals Group.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.